Market Overview

Attis Industries Announces Technologies Division Leadership and Launch of Healthcare Website


MILTON, GA, July 27, 2018 (GLOBE NEWSWIRE) -- Attis Industries Inc. (NASDAQ:ATIS) (the "Company" or "Attis"), an integrated technology and innovations holding company, today announced that Rob Dunn has been appointed as the President of its Technologies Division, which includes both the Attis Healthcare division as well as the Attis mobile apps division, and that it has launched its new Attis Healthcare website ( 

Mr. Dunn, an attorney by trade who has worked for the Company since September of last year, has broad experience leading teams in sales organizations.  As an attorney, Mr. Dunn represented both private and public-sector entities across a wide spectrum of issues. Mr. Dunn also spent a significant amount of time working directly for a multi-national Fortune 500 company in the medical device industry. Mr. Dunn's tenure at this healthcare company included a role as both the lead commercial attorney and the Human Resources leader for the U.S. Sales Division, a division with more than $2.6 Billion in annual revenue and more than 1,600 employees.  Kristin Robinson, VP of Product Marketing, and Ray Waldrop, Director of Operations, also joined the Company in September of 2016.  Ms. Robinson is responsible for developing marketing and product strategies and communications to assist with sales and revenue growth, and Mr. Waldrop leads the operational functions for the Healthcare division.

Additionally, Attis has now launched the website for its Healthcare division, which can be accessed both directly via and through the Attis Industries website ( The new website provides information for customers, partners and investors to better understand the team's target markets and portfolio of best-in-class solutions.

"I'm very pleased to have Rob Dunn leading our Technologies division.  His experience in sales organizations, Kristin's expertise in developing go to market messages and Ray's ability to build and lead operational procedures are perfect fits for what we want to accomplish within Attis and I am confident that they will lead our organization to significant success in the years to come," stated Jeff Cosman, CEO of Attis Industries.  Cosman continued, "I am also excited about the launch of our new Healthcare website, which showcases the exciting technologies that our healthcare team offers."

About Attis Industries Inc.
Attis Industries Inc. (NASDAQ:ATIS) is a holding company defined by our commitment to servicing our customers with unwavering respect, fairness and care. We are focused on finding and implementing solutions for the resource needs and challenges of our customers with a fundamental objective to seek rewarding solutions through technology and innovation. Our healthcare business centers on creating community-based synergies through collaborations and software solutions. Our innovation business strives to create value from recovered resources. For more information, visit:

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "should," "would" or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company's go-forward business, and the risks identified and discussed under the caption "Risk Factors" in the Attis Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission (the "SEC") on April 16, 2018 and the other documents Attis files with the SEC from time to time. There will be events in the future, however, that Attis is not able to predict accurately or control. Attis's actual results may differ materially from the expectations that Attis describes in its forward-looking statements. Factors or events that could cause Attis's actual results to materially differ may emerge from time to time, and it is not possible for Attis to accurately predict all of them. Any forward-looking statement made by Attis in this press release speaks only as of the date on which Attis makes it. Attis undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Media and Investors Contact:
Hayden IR
(917) 658-7878

Primary Logo

View Comments and Join the Discussion!